Medical Science Liaison
Pubblicato il 31-08-2026 - Quetzal Therapeutics in Italia
Contractor Medical Science Liaison (MSL) – Italy/Germany Territory
Candidarsi per questo ruolo è immediato. Scorra verso il basso e faccia clic su "Candidati" per essere preso/a in considerazione per questa posizione.
Haematology / Oncology – Phase 3 Clinical Trial Support
Role Overview
We are seeking an experienced contractor Medical Science Liaison (MSL) to support a multinational Phase 3 haematology/oncology clinical trial across Italy and Germany. This field-based role will focus on scientific engagement with investigators and treatment centres, supporting trial awareness, operational engagement, and high-quality scientific exchange within a compliant framework.
The successful candidate will work independently across a geographically distributed territory and act as a key scientific interface between the company and external stakeholders.
Territory Coverage
Primary territories:
Italy
Germany
Travel within the assigned territory and attendance at relevant scientific meetings/congresses will be required.
Time in Field
Approximately 70–80% field-focused activity expected.
Key Responsibilities
Develop and maintain scientific relationships with investigators, referral centres, and relevant healthcare professionals
Support scientific engagement around an ongoing Phase 3 haematology clinical trial
Deliver high-quality, non-promotional scientific exchange in compliance with applicable regulations and company SOPs
Support trial awareness and operational engagement activities within assigned territories
Identify and communicate field insights, including recruitment challenges, treatment landscape developments, and investigator feedback
Support congress activities, investigator meetings, and scientific discussions as required
Ensure timely and accurate documentation of activities and reporting of adverse events/product complaints in accordance with pharmacovigilance requirements
Work cross-functionally with Medical Affairs, Clinical Operations, and other internal stakehold